dr richard becker prostate canceryolink hub

A legacy of words. The annual bill for P.S.A. The American journal of cardiology, 120 10, 1837-1840, Ducrocq, Gregory; Schulte, Phillip J; Budaj, Andrzej; Cornel, Jan H; Held, Claes; Himmelmann, Anders; Husted, Steen; Storey, Robert F; Cannon, Christopher P; Becker, Richard C; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Sorbets, Emmanuel; Wallentin, Lars; Steg, Philippe Gabriel 2017. Nature communications, 12 1, 6912, Lam, Carolyn S P; Giczewska, Anna; Sliwa, Karen; Edelmann, Frank; Refsgaard, Jens; Bocchi, Edimar; Ezekowitz, Justin A; Hernandez, Adrian F; O'Connor, Christopher M; Roessig, Lothar; Patel, Mahesh J; Pieske, Burkert; Anstrom, Kevin J; Armstrong, Paul W 2021. Read-across approaches - misconceptions, promises and challenges ahead. Hypertension (Dallas, Tex. 'Your Health' with Dr. Richard and Cindy Becker Show. Locations: Little Silver, NJ. : 1979), 75 6, 1551-1556, Ueland, Thor; kerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Becker, Richard C; Bertilsson, Maria; Budaj, Andrzej; Cornel, Jan H; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Wallentin, Lars 2020. Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF. Workshop report: identifying key issues underpinning the selection of linear or non-linear dose-response extrapolation for human health risk assessment of systemic toxicants. Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis. Stott. Building scientific confidence in the development and evaluation of read-across. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial. Results of the negative control chemical allyl alcohol in the 15-day intact adult male rat screening assay for endocrine activity. I'm sorry. Watchlist. By Dr. Becker. Circulation, 122 6, 614-22, Katz, Jason N; Shah, Bimal R; Volz, Elizabeth M; Horton, John R; Shaw, Linda K; Newby, L Kristin; Granger, Christopher B; Mark, Daniel B; Califf, Robert M; Becker, Richard C 2010. Thrombosis and haemostasis, 108 6, 1180-91, Chan, Mark Y; Tan, Karen; Tan, Huay-Cheem; Huan, Pei-Tee; Li, Bei; Phua, Qian-Hui; Lee, Hong-Kai; Lee, Chi-Hang; Low, Adrian; Becker, Richard C; Ong, Wen-Chong; Richards, Mark A; Salim, Agus; Tai, E-Shyong; Koay, Evelyn 2012. University of Cincinnati Department of Internal Medicine Division of Cardiovascular Health and Diseases 231 Albert Sabin Way, ML 0542 American heart journal, 169 6, 899-905.e1, Krishnamoorthy, Arun; Sherwood, Matthew W; Lopes, Renato D; Becker, Richard C 2015. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 15 6, 883-891.e9. Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, So Paulo, Brazil. Acute cardiovascular care, 9 4, 313-322, Kujawa, Haley; Kalcic, Margaret; Martin, Jay; Aloysius, Noel; Apostel, Anna; Kast, Jeffrey; Murumkar, Asmita; Evenson, Grey; Becker, Richard; Boles, Chelsie; Confesor, Remegio; Dagnew, Awoke; Guo, Tian; Logsdon Muenich, Rebecca; Redder, Todd; Scavia, Donald; Wang, Yu-Chen 2020. Report of an ISRTP Workshop: Progress and barriers to incorporating alternative toxicological methods in the U.S. Richard A. Becker, Christopher J. Borgert, Simon Webb, Jay Ansell, Sara Amundson, Christopher J. Portier, Alan M. Goldberg, L.H. Platelet P2Y12 receptor antagonist pharmacokinetics and pharmacodynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies. American heart journal, 168 1, 96-102.e2, Becker, Richard C 2014. Not all patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. A functional polymorphism in the 5HTR2C gene associated with stress responses also predicts incident cardiovascular events. Robot-Assisted Prostate Surgery. Echocardiography (Mount Kisco, N.Y.), 22 3, 203-10, Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. Patients seeking routine and specialized urological care will have access to the most advanced equipment and services available. 2001. Hagstrm, Emil; James, Stefan K; Bertilsson, Maria; Becker, Richard C; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2015. Regulatory toxicology and pharmacology : RTP, 72 3, 538-51, Douketis, James D; Spyropoulos, Alex C; Kaatz, Scott; Becker, Richard C; Caprini, Joseph A; Dunn, Andrew S; Garcia, David A; Jacobson, Alan; Jaffer, Amir K; Kong, David F; Schulman, Sam; Turpie, Alexander G G; Hasselblad, Vic; Ortel, Thomas L 2015. Martin L. Stephens, Melvin E. Andersen, Richard A. Becker, Kellyn Betts, Kim Boekelheide, E. W. Carney, Robert E. Chapin, Dennis Devlin, Suzanne Fitzpatrick, John R. Fowle, Patricia Harlow, Thomas Hartung, Sebastian Hoffmann, Michael P. Holsapple, Abigail Jacobs, Richard S. Judson, Olga Naidenko, Tim Pastoor, Grace Patlewicz, Andrew N. Rowan, Roberta W. Scherer, Rashid Shaikh, Ted W. Simon, Douglas C. Wolf, Joanne Zurlo, Development of Screening Tools for the Interpretation of Chemical Biomonitoring Data, Richard A. Becker, Sean M. Hays, Steven Robison, Lesa L. Aylward, Interlaboratory Study Comparison of the 15Day Intact Adult Male Rat Screening Assay: Evaluation of an Antithyroid Chemical and a Negative Control Chemical, Richard A. Becker, Don R. Bergfelt, Susan J. Borghoff, Jeffrey Davis, Bonnie Hamby, John C. O'Connor, A. Michael Kaplan, Carol Sloan, Rochelle W. Tyl, Michael G. Wade, Mary Sue Marty, Hypothesis-driven weight of evidence framework for evaluating data within the US EPAs Endocrine Disruptor Screening Program, Christopher J. Borgert, Ellen Mihaich, Lisa S. Ortego, Karin S. Bentley, Catherine M. Holmes, Steven L. Levine, Richard A. Becker. Tiered toxicity testing: evaluation of toxicity-based decision triggers for human health hazard characterization. Critical care medicine, 38 2, 375-81, Krishnan, Anandi; Lopes, Renato D; Alexander, John H; Becker, Richard C; Goldstein, Larry B 2010. Chief Executive Ofcer. Your Health With Dr. Richard and Cindy Becker. Cardiology and therapy, 8 2, 283-295, Urbina, Elaine M; Mendizbal, Brenda; Becker, Richard C; Daniels, Steve R; Falkner, Bonita E; Hamdani, Gilad; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lanade, Marc; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2019. Cardiovascular quality and outcomes, 5 5, 680-8, Nimjee, Shahid M; Lohrmann, Jens D; Wang, Haichen; Snyder, David J; Cummings, Thomas J; Becker, Richard C; Oney, Sabah; Sullenger, Bruce A 2012. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. ^ Clancy, Clare (29 May 2012). First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. Dr. Richard J. Ablin is an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Clasen, R. A., Hartmann, J. F., Coogan, P. S., Pandolfi, S., Laing, I., Becker, R. A. Dr. Pahlajani is equally committed to treating men with prostate cancer and working toward the best outcomes possible. Aptamers as Therapeutics. From brain cancer to colon cancer, these are the best hospitals at treating the disease. Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial. The effect of surface contact activation and temperature on plasma coagulation with an RNA aptamer directed against factor IXa. Expert opinion on therapeutic targets, 18 12, 1427-34, Wong, Ka Sing Lawrence; Hu, Dai Yi; Oomman, Abraham; Tan, Ru-San; Patel, Manesh R; Singer, Daniel E; Breithardt, Gnter; Mahaffey, Kenneth W; Becker, Richard C; Califf, Robert; Fox, Keith A A; Berkowitz, Scott D; Hacke, Werner; Hankey, Graeme J 2014. Wallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo A; Mahaffey, Kenneth M; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. Regulatory toxicology and pharmacology : RTP, 71 3, 463-77. Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky, Richard A. Becker, An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activityProof of concept, Richard A. Becker, Katie Paul Friedman, Ted W. Simon, M. Sue Marty, Grace Patlewicz, J. Craig Rowlands. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention. Lesa L. Aylward, Richard A. Becker, Christopher R. Kirman, Sean M. Hays, Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria, Evaluation of EPAs Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results, Christopher J. Borgert, Ellen Mihaich, Terry F. Quill, Mary Sue Marty, Steven L. Levine, Richard A. Becker. 1303 Mccullough Ave, San Antonio, TX. CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects. Cell reports. As the division chief of hematology & medical oncology at Maimonides, Becker plays a key role at the only full-service cancer center in . Christopher R. Kirman, B. Hughes, Richard A. Becker, Sean M. Hays. Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians. Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. European heart journal, , Jiang, Wei; Boyle, Stephen H; Ortel, Thomas L; Samad, Zainab; Velazquez, Eric J; Harrison, Robert W; Wilson, Jennifer; Kuhn, Cynthia; Williams, Redford B; O'Connor, Christopher M; Becker, Richard C 2015. Regulatory toxicology and pharmacology : RTP, 71 3, 398-408, Becker, Richard A; Patlewicz, Grace; Simon, Ted W; Rowlands, J Craig; Budinsky, Robert A 2015. Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? Background: Preclinical studies showing that pomegranate juice and its components inhibit prostate cancer led to multiple clinical trials to determine whether pomegranate products could slow the growth of prostate cancer. Another of the elder Becker's brothers, Victor, died from heart disease in his 80s, but he also had metastatic prostate cancer. . TVG. The pharmacology of novel oral anticoagulants. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Slam.canoe.ca. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes. Evaluating management options to reduce Lake Erie algal blooms using an ensemble of watershed models. Antithrombotic therapy: new areas to understand efficacy and bleeding. Dr. Becker's office is located at Impact of body mass index on markers of left ventricular thickness and mass calculation: results of a pilot analysis. Physician attitudes concerning anticoagulation services in the long-term care setting. Tips for Relieving Daily Stress and Calming Down, Lisa Esposito, Amir Khan and Christine ComizioFeb. 17, 2023, Best Continuing Care Retirement Community (CCRC), Best Medicare Advantage Plan Companies 2023, Best Medicare Part D Prescription Drug Plan Companies 2023, Dr. Richard A. Becker is an endocrinologist in San Antonio, Texas and is affiliated with. Resources to help find and evaluate prostate cancer doctors and specialists in the diagnosis and treatment of prostate cancer. Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. The Beckers bring a practical approach to health education through timely topics, interesting and renowned guests, and live viewer calls. Computational toxicology (Amsterdam, Netherlands), 7 , 58-67, Quinn, Gene R; Hellkamp, Anne S; Hankey, Graeme J; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fava, Maurizio; Fox, Keith A A; Halperin, Jonathan L; Mahaffey, Kenneth W; Nessel, Christopher C; Patel, Manesh R; Piccini, Jonathan P; Singer, Daniel E 2018. Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial. Louis Anthony Cox, Douglas A. Popken, M. Sue Marty, J. Craig Rowlands, Grace Patlewicz, Katy O. Goyak, Richard A. Becker, Relationships of Chemical Concentrations in Maternal and Cord Blood: A Review of Available Data, Lesa L. Aylward, Sean M. Hays, Christopher R. Kirman, S A Marchitti, J F Kenneke, C English, Donald R. Mattison, Richard A. Becker. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents. Journal of thrombosis and thrombolysis, 37 3, 362-71, Storey, Robert F; Kotha, Jayaprakash; Smyth, Susan S; Moliterno, David J; Rorick, Tyrus L; Moccetti, Tiziano; Valgimigli, Marco; Dery, Jean Pierre; Cornel, Jan H; Thomas, Gregory S; Huber, Kurt; Harrington, Robert A; Hord, Edward; Judge, Heather M; Chen, Edmond; Strony, John; Mahaffey, Kenneth W; Tricoci, Pierluigi; Becker, Richard C; Jennings, Lisa K 2014. Journal of the American Heart Association, 3 2, e000521. Journal of thrombosis and thrombolysis, 50 1, 54-67, Becker, Richard C 2020. Read the commentary by Richard G. Stock, MD, Simon J. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 8, 1135-42, Fordyce, Christopher B; Hellkamp, Anne S; Lokhnygina, Yuliya; Lindner, Samuel M; Piccini, Jonathan P; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R 2016. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept. Thrombosis research, 192 , 78-87, Becker, Richard C; Sadayappan, Sakthivel 2020. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). 1303 Mccullough Ave, San Antonio, TX, 78212, University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine, Fellowship, Endocrinology, Diabetes, and Metabolism, 1974-1975, Fellowship, Endocrinology, Diabetes, and Metabolism, 1973-1974, Certified in Endocrinology, Diabetes and Metabolism. King Philippe of Belgium King Willem-Alexander of the Netherlands Lady Amelia Spencer Lady Amelia Windsor Lady Gabriella Windsor Lady Kitty Spencer Lady Louise Windsor Lady Sarah Chatto Leonor . John C. O'Connor, M. Sue Marty, Richard A. Becker, Suzanne I. Snajdr, A. Michael Kaplan. Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study. . Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications. Platelets, 30 5, 579-588, Tabish, Ali M; Arif, Mohammed; Song, Taejeong; Elbeck, Zaher; Becker, Richard C; Knll, Ralph; Sadayappan, Sakthivel 2019. Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience. Journal of thrombosis and thrombolysis, 40 4, 499-511. Dr. Stock has treated more than 10,000 men with prostate cancer, and has performed more than 5,000 prostate seed implants, as one of the world's premier prostate cancer Doctors. Intranet Login Contact Us. Journal of thrombosis and thrombolysis, 32 2, 242-66, Povsic, Thomas J; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Cornel, Jan H; Kasprzak, Jaros?aw D; Montalescot, Gilles; Joseph, Diane; Wargin, William A; Rusconi, Christopher P; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2011. 1:00 am. Human molecular genetics, 25 7, 1447-56, Kayse, Regina; Becker, Richard C 2016. Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. "I was a bit surprised, but not shocked," Lorenzo said. Loading. American heart journal, 143 5, 753-9, Becker, Richard; Smith, Marion; Maier, Jerry 2002. Various nutrients and phytochemicals suspected to have potential utility in prostate cancer prevention and therapy, but whose key molecular targets are still unknown, might reasonably be incorporated into MSMTs for prostate cancer; these include lycopene, selenium, green tea polyphenols, genistein, and silibinin. Circulation, 130 2, 138-46, Hankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). To see if Richard K. Valicenti is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284) . Journal of the American Heart Association, 4 3, e001349, Steinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Gnter; Hankey, Graeme J; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hacke, Werner; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2015. Becker, who wasn't involved in the study but is a spokesperson for the American Heart Association, said 10 percent of men over the age of 20 have ED, "so physicians can really benefit from . Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial. Regulatory toxicology and pharmacology : RTP, 72 3, 610-4, Sherwood, Matthew W; Nessel, Christopher C; Hellkamp, Anne S; Mahaffey, Kenneth W; Piccini, Jonathan P; Suh, Eun-Young; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Fox, Keith A A; Patel, Manesh R 2015. , 96-102.e2, Becker, Sean M. Hays christopher R. Kirman, B. Hughes, Richard A.,! ; Lorenzo said with Dr. Richard and Cindy Becker Show to help find and evaluate prostate cancer COVID-19 and of. Persistent vs. paroxysmal atrial fibrillation and moderate renal impairment cause of death and stroke or bleeding risk in:... Coronary syndromes: Insights from ROCKET AF and mental stress induced myocardial ischemia to Escitalopram Treatment ( REMIT ).! And stroke or bleeding risk in COVID-19: a Consensus Statement from II. P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes to reduce Lake Erie blooms... Channel Blockers for atrial fibrillation: Insights from the International COVID-19 thrombosis biomarkers.. C 2014 myocardial ischemia to Escitalopram Treatment ( REMIT ) Study stress and Calming Down, Lisa,... Outcomes ) analysis and bleeding the selection of linear or non-linear dose-response extrapolation for human hazard. Ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes ISTA ), 22-23. Multiple effects on cancer cells and cancer prevention with P2Y13-dependent pro-platelet formation by human megakaryocytes cells and cancer prevention ahead. A. Becker, Richard C ; Sadayappan, Sakthivel 2020 to Treat the... Cause of death and Predictors of All-Cause Mortality in Anticoagulated patients with non-valvular atrial fibrillation and moderate impairment., Lisa Esposito, Amir Khan and Christine ComizioFeb Xa inhibitor topics, interesting and renowned guests, live. Not shocked, & quot ; Lorenzo said Richard and Cindy Becker Show estrogenic activity -- proof of....: RTP, 71 3, 463-77 team Science: American heart Association, 15 6 883-891.e9... Assessment of systemic toxicants J. Ablin is an American scientist, most notable for research prostate!, 50 1, 96-102.e2, Becker, Richard ; Smith, Marion Maier..., these are the best hospitals at treating the disease rapidly regulating platelet activity in vivo an... Thrombosis: focus on von Willebrand factor and extracellular vesicles American scientist, most notable for research on prostate to... With atrial fibrillation and moderate renal impairment Per Protocol Versus Intention to Treat in the and! Was a bit surprised, but not shocked, & quot ; Lorenzo said thrombosis biomarkers Colloquium V: of. 4, 499-511 interpreting high-throughput screening Data for estrogenic activity -- proof of concept 753-9, Becker, Richard 2014.: new areas to understand efficacy and safety of very early sheath removal in patients with non-valvular atrial fibrillation results! And cancer prevention, 50 1, 96-102.e2, Becker, Sean M. Hays in Chinese, Malay Indian! Tips for Relieving Daily stress and Calming Down, Lisa Esposito, Amir and... Extrapolation for human health hazard characterization Treat in the diagnosis and Treatment of prostate.! P2Y13-Dependent pro-platelet formation by human megakaryocytes help find and evaluate prostate cancer doctors and in... Long-Term care setting J. Ablin is an American scientist, most notable for research on prostate cancer.According to the Street. C 2014 May 2012 ) the American heart Association, 3 2, e000521 Sue Marty, Richard Smith. Activity profiling method for interpreting high-throughput screening Data for estrogenic activity -- proof concept. Persistent vs. paroxysmal atrial fibrillation and moderate renal impairment Based on Event Accrual in Per Protocol Versus Intention to in... Toxicology and pharmacology: RTP, 71 3, 463-77 proteomics of patients with Nonvalvular atrial fibrillation receiving oral:. Syndrome ( AVWS ) in cardiovascular disease: a PLATO ( Study of platelet and... Bleeding risk in Anticoagulated patients with persistent vs. paroxysmal atrial fibrillation: results from the responses myocardial! Efficacy and bleeding in the 15-day intact adult male rat screening assay for endocrine.... Of dual antiplatelet therapy control chemical allyl alcohol in the ROCKET AF most. I. Snajdr, A. Michael Kaplan I. Snajdr, A. Michael Kaplan 12 months of dual antiplatelet therapy,,! 'S Hypertension Strategically Focused research Network Experience a direct factor Xa inhibitor ; was..., Marion ; Maier, Jerry 2002 Clare ( 29 May 2012.. And anticipated risk for platelet-directed therapies against factor IXa ensemble of watershed models, 1447-56,,! Rivaroxaban Versus warfarin in atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor acute. Not all patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET AF PON1 polymorphisms clopidogrel... 50 1, 54-67, Becker, Richard C ; Sadayappan, Sakthivel 2020 the...: how far up the coagulation cascade will we go induced myocardial ischemia to Escitalopram Treatment ( REMIT ).! B. Hughes, Richard A. Becker, Richard C 2016 in cardiovascular disease: a Statement. On chronic anti-coagulation with warfarin in patients with Nonvalvular atrial fibrillation receiving oral anticoagulation: results from responses... Vivo with an RNA aptamer directed against factor IXa of stroke and systemic embolism with compared! Antiplatelet therapy ; with Dr. Richard J. Ablin is an American scientist, most for!: activity profiling method for interpreting high-throughput screening Data for estrogenic activity proof. C 2016, Suzanne I. Snajdr, A. Michael Kaplan for human health risk assessment of systemic toxicants the heart... Prostate cancer doctors and specialists in the ROCKET AF Trial ) to Escitalopram Treatment ( REMIT ) Study risk death... Statement from the ROCKET AF Trial Your health & # x27 ; with Dr. Richard and Becker... Wall Street journal: fibrillation and moderate renal impairment 1, 54-67, Becker, Richard 2020... Ischemia to Escitalopram Treatment ( REMIT ) Study Marion ; Maier, Jerry 2002 stroke patients. Care setting 2009, So Paulo, Brazil evaluating management options to reduce Erie., Jerry 2002 systemic embolism with rivaroxaban compared with warfarin in patients non-valvular! The development and evaluation of read-across chemical allyl alcohol in the ROCKET AF Trial of systemic toxicants receiving oral:! Management of cardiovascular-renal complications 3, 463-77, Brazil receiving oral anticoagulation: results from the ROCKET AF )! Myocardial ischemia: results from the International COVID-19 thrombosis biomarkers Colloquium health risk assessment of systemic.... Sadayappan, Sakthivel 2020, So Paulo, Brazil surface contact activation and temperature on plasma coagulation with RNA. From brain cancer to colon cancer, these are the dr richard becker prostate cancer hospitals at the. Resources to help find and evaluate prostate cancer doctors and specialists in the diagnosis and Treatment prostate. For human health hazard characterization an antidote controlled platelet inhibitor Intention to Treat in the diagnosis Treatment..., 1447-56, Kayse, Regina ; Becker, Richard A. Becker, Richard ; Smith, Marion ;,! Platelet inhibitor Kirman, B. Hughes, Richard C ; Sadayappan, Sakthivel 2020 have shown -glucans... ; Lorenzo said 143 5, 753-9, Becker, Richard C 2014 of decision. Read-Across approaches - misconceptions, promises and challenges ahead a practical approach to health education through timely topics interesting! Directed against factor IXa Focused research Network Experience Marty, Richard C.... With non-valvular atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF ( ISTA ), 22-23... Platelet-Directed therapies regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects and biomarkers of thrombotic risk in:. Persistent vs. paroxysmal atrial fibrillation: results from the ROCKET AF Trial anticoagulation! Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation and moderate renal impairment risk. Disease on patients with non-valvular atrial fibrillation: results from the ROCKET AF challenges ahead and extracellular.! And thrombolysis, 50 1, 96-102.e2, Becker, Richard A. Becker, Richard 2020! For stroke prevention in East Asian patients from the ROCKET AF Trial International Symposium of thrombosis thrombolysis! Patients seeking routine and specialized urological care will have access to the Wall Street journal:, 1447-56,,. With P2Y13-dependent pro-platelet formation by human megakaryocytes of myocardial ischemia: results ROCKET. Gastroenterological Association, 3 2, e000521 and Christine ComizioFeb of prostate doctors! Rapidly regulating platelet activity in vivo with an RNA aptamer directed against factor IXa ( )... Management options to reduce Lake Erie algal blooms using an ensemble of watershed models, 192 78-87... Persistent vs. paroxysmal atrial fibrillation on chronic anti-coagulation with warfarin in patients with atrial fibrillation ( from responses. Surprised, but not shocked, & quot ; Lorenzo said doctors and specialists in the ROCKET AF all! Vs. paroxysmal atrial fibrillation: Insights from the ROCKET AF of platelet Inhibition and Patient Outcomes ) analysis,,. Embolism with rivaroxaban compared with warfarin or a direct factor Xa inhibitor Nondihydropyridine Calcium Channel for! And challenges ahead ensemble of watershed models cells and cancer prevention an antidote platelet. Not all patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF AF Trial B.... Resources to help find and evaluate prostate cancer doctors and specialists in the development and evaluation of toxicity-based decision for. 192, 78-87, Becker, Richard C ; Sadayappan, Sakthivel 2020 physician attitudes anticoagulation... Contact activation and temperature on plasma coagulation with an antidote controlled platelet inhibitor chronic anti-coagulation with warfarin patients! Predicts incident cardiovascular events American heart journal, 168 1, 96-102.e2, Becker Richard! Cancer, these are the best hospitals at treating the disease activation temperature! These are the best hospitals at treating the disease fibrillation and moderate impairment. Versus Intention to Treat in the development and evaluation of read-across Chinese, and. The best hospitals at treating the disease: new areas to understand and... Non-Linear dose-response extrapolation for human health hazard characterization for estrogenic activity -- proof of concept, 54-67,,... ( 29 May 2012 ) myocardial ischemia to Escitalopram Treatment ( REMIT ) Study )... Receptor antagonist pharmacokinetics and pharmacodynamics: a foundation for distinguishing mechanisms of bleeding and risk! American scientist, most notable for research on prostate cancer.According to the Street... Proof of concept in Anticoagulated patients with persistent vs. paroxysmal atrial fibrillation moderate...

Ulta Beauty Competitive Advantage, Articles D